Clinical Trials
2 trialsNCT00293423 2021-05-13
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
University of California, San Francisco
Phase 1/2 Completed
NCT02452281 2016-01-25
Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma
The University of Texas Health Science Center, Houston
Phase 1/2 Withdrawn